Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Leukemia

 

Free Subscription


16.04.2008

1 Am J Hematol
4 Ann Hematol
2 Biochem Pharmacol
2 Blood
26 Br J Haematol
1 Cancer Chemother Pharmacol
1 Cancer Lett
1 Exp Cell Res
1 Genes Chromosomes Cancer
3 J Clin Oncol
2 J Natl Cancer Inst
1 J Pediatr Hematol Oncol
30 Leuk Lymphoma
2 Leukemia
1 Nat Rev Cancer
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. RODIG SJ , Payne EG, Degar BA, Rollins B, et al
    Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
    Am J Hematol. 2008;83:116-21.
    PubMed     Related articles    Abstract available


    Ann Hematol


  2. Abstracts of Acute Leukemias XII : biology and treatment strategies. February 16-20, 2008. Munich, Germany.
    Ann Hematol. 2008;87 Suppl 1:S1-98.
    PubMed     Related articles   

  3. FORSTER K , Obermeier A, Mitina O, Simon N, et al
    Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells.
    Ann Hematol. 2008;87:183-93.
    PubMed     Related articles    Abstract available

  4. CHEN CH , Lin JY, Liu FH, Chang JL, et al
    Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells.
    Ann Hematol. 2008;87:175-82.
    PubMed     Related articles    Abstract available

  5. LASA A , Serrano E, Carricondo M, Carnicer MJ, et al
    High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
    Ann Hematol. 2008;87:205-11.
    PubMed     Related articles    Abstract available


    Biochem Pharmacol

  6. BASTIN-COYETTE L , Smal C, Cardoen S, Saussoy P, et al
    Mechanisms of cell death induced by 2-chloroadenosine in leukemic B-cells.
    Biochem Pharmacol. 2008;75:1451-60.
    PubMed     Related articles    Abstract available

  7. RIVEIRO ME , Vazquez R, Moglioni A, Gomez N, et al
    Biochemical mechanisms underlying the pro-apoptotic activity of 7,8-dihydroxy-4-methylcoumarin in human leukemic cells.
    Biochem Pharmacol. 2008;75:725-36.
    PubMed     Related articles    Abstract available


    Blood

  8. JABBOUR E , Kantarjian H, Jones D, Breeden M, et al
    Characteristics and outcome of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy.
    Blood. 2008;.
    PubMed     Related articles    Abstract available

  9. MARKS DI , Perez WS, He W, Zhang MJ, et al
    Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
    Blood. 2008;.
    PubMed     Related articles    Abstract available


    Br J Haematol


  10. Abstracts of the British Society of Haematology 48th Annual Scientific Meeting, Incorporating the 6th Bi-Annual I-BFM Leukaemia Symposium. April 7-9, 2008.
    Br J Haematol. 2008;141 Suppl 1:1-121.
    PubMed     Related articles   

  11. HARDY NM , Grady C, Pentz R, Stetler-Stevenson M, et al
    Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.
    Br J Haematol. 2007;139:824-31.
    PubMed     Related articles    Abstract available

  12. GOLDIN LR , Caporaso NE
    Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
    Br J Haematol. 2007;139:774-9.
    PubMed     Related articles    Abstract available

  13. SHAPIRO HM
    Cytometry in monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia--the Hunting of the Snark?
    Br J Haematol. 2007;139:772-3.
    PubMed     Related articles    Abstract available

  14. SLAGER SL , Kay NE, Fredericksen ZS, Wang AH, et al
    Susceptibility genes and B-chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:762-71.
    PubMed     Related articles    Abstract available

  15. RAWSTRON AC , Bennett F, Hillmen P
    The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:724-9.
    PubMed     Related articles    Abstract available

  16. LANDGREN O , Kyle RA
    Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases.
    Br J Haematol. 2007;139:717-23.
    PubMed     Related articles    Abstract available

  17. NICOLOSO MS , Kipps TJ, Croce CM, Calin GA, et al
    MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:709-16.
    PubMed     Related articles    Abstract available

  18. MARTI G , Abbasi F, Raveche E, Rawstron AC, et al
    Overview of monoclonal B-cell lymphocytosis.
    Br J Haematol. 2007;139:701-8.
    PubMed     Related articles    Abstract available

  19. VOGT RF , Shim YK, Middleton DC, Buffler PA, et al
    Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies.
    Br J Haematol. 2007;139:690-700.
    PubMed     Related articles    Abstract available

  20. VOGT RF , Marti GE
    Overview of monoclonal gammopathies of undetermined significance.
    Br J Haematol. 2007;139:687-9.
    PubMed     Related articles    Abstract available

  21. LINET MS , Schubauer-Berigan MK, Weisenburger DD, Richardson DB, et al
    Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.
    Br J Haematol. 2007;139:672-86.
    PubMed     Related articles    Abstract available

  22. MCMASTER ML , Caporaso N
    Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
    Br J Haematol. 2007;139:663-71.
    PubMed     Related articles    Abstract available

  23. SHIM YK , Silver SR, Caporaso NE, Marti GE, et al
    B cells behaving badly.
    Br J Haematol. 2007;139:658-62.
    PubMed     Related articles    Abstract available

  24. CAPORASO N , Goldin L, Plass C, Calin G, et al
    Chronic lymphocytic leukaemia genetics overview.
    Br J Haematol. 2007;139:630-4.
    PubMed     Related articles    Abstract available

  25. RAWSTRON AC , Jones RA, Ferguson C, Hughes G, et al
    Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.
    Br J Haematol. 2007;139:845-8.
    PubMed     Related articles    Abstract available

  26. RACHEL JM , Zucker ML, Fox CM, Plapp FV, et al
    Monoclonal B-cell lymphocytosis in blood donors.
    Br J Haematol. 2007;139:832-6.
    PubMed     Related articles    Abstract available

  27. BLAIR A , Purdue MP, Weisenburger DD, Baris D, et al
    Chemical exposures and risk of chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:753-61.
    PubMed     Related articles    Abstract available

  28. PLASS C , Byrd JC, Raval A, Tanner SM, et al
    Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes.
    Br J Haematol. 2007;139:744-52.
    PubMed     Related articles    Abstract available

  29. AUER RL , Gribben J, Cotter FE
    Emerging therapy for chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:635-44.
    PubMed     Related articles    Abstract available

  30. JOHNSON AJ , Wagner AJ, Cheney CM, Smith LL, et al
    Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:837-44.
    PubMed     Related articles    Abstract available

  31. DORES GM , Anderson WF, Curtis RE, Landgren O, et al
    Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available

  32. SCAGLIONE BJ , Salerno E, Balan M, Coffman F, et al
    Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
    Br J Haematol. 2007;139:645-57.
    PubMed     Related articles    Abstract available

  33. LANDGREN O , Gridley G, Check D, Caporaso NE, et al
    Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:791-8.
    PubMed     Related articles    Abstract available

  34. ABBASI F , Longo NS, Lipsky PE, Raveche E, et al
    B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred.
    Br J Haematol. 2007;139:820-3.
    PubMed     Related articles    Abstract available

  35. SCHUBAUER-BERIGAN MK , Daniels RD, Fleming DA, Markey AM, et al
    Chronic lymphocytic leukaemia and radiation: findings among workers at five US nuclear facilities and a review of the recent literature.
    Br J Haematol. 2007;139:799-808.
    PubMed     Related articles    Abstract available


    Cancer Chemother Pharmacol

  36. THOMADAKI H , Tsiapalis CM, Scorilas A
    The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines.
    Cancer Chemother Pharmacol. 2008;61:703-11.
    PubMed     Related articles    Abstract available


    Cancer Lett

  37. KIM HJ , Oh JE, Kim SW, Chun YJ, et al
    Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells.
    Cancer Lett. 2008;260.
    PubMed     Related articles    Abstract available


    Exp Cell Res

  38. YAMADA T , Shimizu T, Suzuki M, Kihara-Negishi F, et al
    Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
    Exp Cell Res. 2008;314:847-58.
    PubMed     Related articles    Abstract available


    Genes Chromosomes Cancer

  39. MATTARUCCHI E , Guerini V, Rambaldi A, Campiotti L, et al
    Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia.
    Genes Chromosomes Cancer. 2008;.
    PubMed     Related articles    Abstract available


    J Clin Oncol

  40. RIBERA JM , Oriol A, Sanz MA, Tormo M, et al
    Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96.
    J Clin Oncol. 2008;26:1843-9.
    PubMed     Related articles    Abstract available

  41. DIGIOVANNA MP , Stern DF, Edgerton S, Broadwater G, et al
    Influence of Activation State of ErbB-2 (HER-2) on Response to Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil for Stage II, Node-Positive Breast Cancer: Study 8541 From the Cancer and Leukemia Group B.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available

  42. DILLMAN RO
    Immunophenotyping of chronic lymphoid leukemias.
    J Clin Oncol. 2008;26:1193-4.
    PubMed     Related articles   


    J Natl Cancer Inst

  43. KANG MH , Wan Z, Kang YH, Sposto R, et al
    Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 Inactivation.
    J Natl Cancer Inst. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text


  44. Stat Bite: Estimated New Leukemia Cases in 2008.
    J Natl Cancer Inst. 2008;.
    PubMed     Related articles   


    J Pediatr Hematol Oncol

  45. AKIYAMA M , Yamada O, Agawa M, Yuza Y, et al
    Effects of Prednisolone on Specifically Expressed Genes in Pediatric Acute B-lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2008;30:313-316.
    PubMed     Related articles    Abstract available


    Leuk Lymphoma


  46. Additional abstracts from the XII International Workshop on Chronic Lymphocytic Leukemia. September 14-16, 2007. London, United Kingdom.
    Leuk Lymphoma. 2007;48:2267-74.
    PubMed     Related articles   

  47. PROCHOREC-SOBIESZEK M , Chelstowska M, Rymkiewicz G, Majewski M, et al
    Biclonal T-cell receptor gammadelta+ large granular lymphocyte leukemia associated with rheumatoid arthritis.
    Leuk Lymphoma. 2008;49:828-31.
    PubMed     Related articles   

  48. BROWN NM , Keck G, Ford PA
    Acute myeloid leukemia in Jehovah Witnesses.
    Leuk Lymphoma. 2008;49:817-20.
    PubMed     Related articles   

  49. SAULNIER PJ , Dalbies F, Berthou C, Guilhot F, et al
    Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy.
    Leuk Lymphoma. 2008;49:815-6.
    PubMed     Related articles   

  50. ADAMS DJ , Sandvold ML, Myhren F, Jacobsen TF, et al
    Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
    Leuk Lymphoma. 2008;49:786-97.
    PubMed     Related articles    Abstract available

  51. GALLIGAN L , Catherwood MA, Matthews C, Morris TC, et al
    Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:763-8.
    PubMed     Related articles    Abstract available

  52. KIKUCHI A , Mori T, Fujimoto J, Kumagai M, et al
    Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.
    Leuk Lymphoma. 2008;49:757-62.
    PubMed     Related articles    Abstract available

  53. YU Z , Sun B, Kantarjian HM, Keating MJ, et al
    Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators.
    Leuk Lymphoma. 2008;49:751-6.
    PubMed     Related articles    Abstract available

  54. TSURUSAWA M , Taga T, Horikoshi Y, Ogawa A, et al
    Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group.
    Leuk Lymphoma. 2008;49:734-9.
    PubMed     Related articles    Abstract available

  55. KHAN NI , Cisterne A, Devidas M, Shuster J, et al
    Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics.
    Leuk Lymphoma. 2008;49:710-8.
    PubMed     Related articles    Abstract available

  56. LEE JH , Min YH, Chung CW, Kim BK, et al
    Prognostic implications of the immunophenotype in biphenotypic acute leukemia.
    Leuk Lymphoma. 2008;49:700-9.
    PubMed     Related articles    Abstract available

  57. HARTMANN EM , Rosenwald A
    Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?
    Leuk Lymphoma. 2008;49:648-9.
    PubMed     Related articles   

  58. SCHMIDT S , Gastl G, Wolf D
    Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:643-7.
    PubMed     Related articles    Abstract available

  59. CLARK RE , Davies A, Pirmohamed M, Giannoudis A, et al
    Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:639-42.
    PubMed     Related articles    Abstract available

  60. VALENT P , Agis H, Sperr W, Sillaber C, et al
    Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:635-8.
    PubMed     Related articles    Abstract available

  61. GUILHOT F , Roy L, Saulnier PJ, Guilhot J, et al
    Immunotherapeutic approaches in chronic myelogenous leukemia.
    Leuk Lymphoma. 2008;49:629-34.
    PubMed     Related articles    Abstract available

  62. SAGLIO G , Ulisciani S, Bosa M, Cilloni D, et al
    New therapeutic approaches and prognostic factors in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:625-8.
    PubMed     Related articles    Abstract available

  63. VALENT P , Deininger M
    Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:604-9.
    PubMed     Related articles    Abstract available

  64. ARLINGHAUS R , Leng X
    Requirement of lipocalin 2 for chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:600-3.
    PubMed     Related articles    Abstract available

  65. VALENT P
    Targets and targeted drugs in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:599.
    PubMed     Related articles   

  66. KOBAYASHI K , Yokote T, Akioka T, Hara S, et al
    Granulocyte colony-stimulating factor and interleukin-6 production by myelodysplastic syndrome blasts.
    Leuk Lymphoma. 2008;49:589-91.
    PubMed     Related articles   

  67. BURKE LP , Kukoly CA
    Statins induce lethal effects in acute myeloblastic lymphoma cells within 72 hours.
    Leuk Lymphoma. 2008;49:322-30.
    PubMed     Related articles    Abstract available

  68. KRAJ M , Sokolowska U, Kopec-Szlezak J, Poglod R, et al
    Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma.
    Leuk Lymphoma. 2008;49:298-305.
    PubMed     Related articles    Abstract available

  69. ZHANG L , Arrington S, Keung YK
    Guillain-Barre syndrome after transplantation.
    Leuk Lymphoma. 2008;49:291-7.
    PubMed     Related articles    Abstract available

  70. HUI D , Lam W, Toze C, Delorme M, et al
    Alemtuzumab in clinical practice: a British Columbia experience.
    Leuk Lymphoma. 2008;49:218-26.
    PubMed     Related articles    Abstract available

  71. SPERR W , Valent P
    Biology and clinical features of myeloid neoplasms with inv(3)(q21q26) or t(3;3)(q21q26).
    Leuk Lymphoma. 2007;48:2096-7.
    PubMed     Related articles   

  72. WEISSER M , Haferlach C, Haferlach T, Schnittger S, et al
    Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.
    Leuk Lymphoma. 2007;48:2145-51.
    PubMed     Related articles    Abstract available

  73. MENG Y , Li Y, Li J, Li H, et al
    (-)Gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemic cells.
    Leuk Lymphoma. 2007;48:2204-12.
    PubMed     Related articles    Abstract available

  74. RAJAPPA S , Varadpande L, Paul TR, Digumarti R, et al
    Imatinib mesylate induced immune thrombocytopenia.
    Leuk Lymphoma. 2007;48:2261-3.
    PubMed     Related articles   

  75. AU WY , Tam S, Fong BM, Ho KL, et al
    Prolonged oral arsenic trioxide therapy and nephrolithiasis [corrected]
    Leuk Lymphoma. 2007;48:2233-4.
    PubMed     Related articles   


    Leukemia

  76. HOCHHAUS A , Baccarani M, Deininger M, Apperley JF, et al
    Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available

  77. BONHOURE E , Lauret A, Barnes DJ, Martin C, et al
    Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available


    Nat Rev Cancer

  78. SHIMIZU R , Engel JD, Yamamoto M
    GATA1-related leukaemias.
    Nat Rev Cancer. 2008;8:279-87.
    PubMed     Related articles    Abstract available


    Oncogene

  79. CANO F , Drynan LF, Pannell R, Rabbitts TH, et al
    Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.
    Oncogene. 2008;27:1945-50.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: